Doximity, Inc. (DOCS) Revenue History
Annual and quarterly revenue from 2019 to present
DOCS Revenue Over Time (2019–2026)
DOCS Revenue Growth History
7 of 7 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- +35.8%
- FY2021 revenue growth
- +77.8%
- FY2022 revenue growth
- +66.0%
- FY2023 revenue growth
- +22.0%
- FY2024 revenue growth
- +13.5%
- FY2025 revenue growth
- +20.0%
- FY2026 revenue growth
- +13.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2026 | $145.4M | +5.1% |
| Q3 2026 | $185.1M | +9.8% |
| Q2 2026 | $168.5M | +23.2% |
| Q1 2026 | $145.9M | +15.2% |
| Q4 2025 | $138.3M | +17.1% |
| Q3 2025 | $168.6M | +24.6% |
| Q2 2025 | $136.8M | +20.4% |
| Q1 2025 | $126.7M | +16.8% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2026)
DOCS's revenue distribution by segment and geography for fiscal year 2026
By Product/Segment
DOCS Revenue Analysis (2019–2026)
Current Revenue & Growth
As of June 13, 2026, Doximity, Inc. (DOCS) generated trailing twelve-month (TTM) revenue of $644.9 million, reflecting solid growth of +5.1% year-over-year. The most recent quarter (Q4 2026) recorded $145.4 million in revenue, down 21.4% sequentially.
Historical Growth Trajectory
DOCS's 5-year compound annual growth rate (CAGR) stands at +25.5%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +15.5% is below the 5-year average, signalling a growth deceleration in recent years. Doximity, Inc.'s highest annual revenue of $644.9 million was recorded in 2026, an all-time high.
Revenue by Segment
DOCS's revenue is primarily driven by Subscription (94%), and Service, Other (6%). With over half of revenue concentrated in Subscription, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including HIMS (+32.8% YoY), WELL (+38.3% YoY), and NVCR (+8.5% YoY) — DOCS has underperformed the peer group in revenue growth. Compare DOCS vs HIMS →
DOCS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 DOCSCurrent | $645M | +5.1% | +25.5% | 33.3% | |
 HIMS | $2.3B | +32.8% | +73.6% | 4.5% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 VEEV | $3.2B | +16.2% | +16.9% | 28.7% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
DOCS Historical Revenue Data (2019–2026)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $644.9M | +13.1% | $574.5M | 89.1% | $214.9M | 33.3% |
| 2025 | $570.4M | +20.0% | $514.5M | 90.2% | $227.8M | 39.9% |
| 2024 | $475.4M | +13.5% | $424.8M | 89.3% | $163.9M | 34.5% |
| 2023 | $419.1M | +22.0% | $365.6M | 87.2% | $125.1M | 29.9% |
| 2022 | $343.5M | +66.0% | $303.8M | 88.4% | $113.5M | 33.0% |
| 2021 | $206.9M | +77.8% | $175.7M | 84.9% | $53.3M | 25.8% |
| 2020 | $116.4M | +35.8% | $101.5M | 87.2% | $22.2M | 19.0% |
| 2019 | $85.7M | - | $74.8M | 87.3% | $6.9M | 8.1% |
What if you invested $1,000 in DOCS back in 2019?
Total return with dividends reinvested · 7+ years of data
Calculate ReturnsHow much would $100/month in DOCS be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs DOCS Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationDOCS vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowDOCS — Frequently Asked Questions
Quick answers to the most common questions about buying DOCS stock.
Is DOCS's revenue growth accelerating or slowing?
DOCS revenue growth is holding steady at +5.1% year-over-year. TTM revenue is $645M. The current growth rate closely tracks the 5-year CAGR of +25.5%, signalling consistent execution.
What is DOCS's revenue history from 2019 to 2026?
Doximity, Inc. (DOCS) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $645M, growing at +5.1% YoY. The 5-year CAGR is +25.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is DOCS's long-term revenue growth rate (CAGR)?
Doximity, Inc.'s 5-year revenue CAGR of +25.5% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +5.1% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for DOCS.
Why does DOCS's quarterly revenue fluctuate?
DOCS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Doximity, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is DOCS's revenue distributed by segment?
DOCS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does DOCS's revenue compare to industry peers?
Doximity, Inc. (DOCS) with TTM revenue of $645M and +5.1% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.